{"filing": {"accession": "0001213900-26-091002", "cik": "0002023016", "ticker": "TTRX", "company_name": "Turn Therapeutics Inc.", "form_type": "8-K", "filing_type": "8-K", "filing_date": "2026-08-18", "accepted_datetime": null, "acceptance_datetime": null, "accepted_at": null, "primary_doc_url": "https://www.sec.gov/Archives/edgar/data/2023016/000121390026091002/0001213900-26-091002-index.htm", "filing_url": "https://www.sec.gov/Archives/edgar/data/2023016/000121390026091002/0001213900-26-091002-index.htm", "period_of_report": "2026-08-13"}, "html_url": "/api/filings/000121390026091002/stream", "exhibits": [], "sections": [], "tables": [{"table_index": 0, "table_type": "text", "caption": null, "header_text": "Delaware001-4287532-0456090"}, {"table_index": 1, "table_type": "text", "caption": null, "header_text": "250 N. Westlake Blvd.,Westlake Village,California91362"}, {"table_index": 2, "table_type": "text", "caption": null, "header_text": "\u2610Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)"}, {"table_index": 4, "table_type": "text", "caption": null, "header_text": "TURN THERAPEUTICS INC."}], "exhibits_pending": false, "cdn_html": true, "response_time_ms": 38}